Table 4. Effects of Roxadustat on lipid profile.

ECB: Estimation Change from the Baseline. EPO: Erythropoietin. M: Month. Roxa: Roxadustat. SD: Standard Deviation

Group		baseline	M1	ECB1	p	M2	ECB2	p	M3	ECB3	p	M6	ECB6	p
Total Cholesterol (mmol/l)
Roxa	Mean	3.98	3.49	-0.48	0.001	3.42	-0.55	0.001	3.38	-0.59	0.012	3.61	-0.398	0.465
	SD	1.2	1.19	0.83		1.07	0.94		1.13	1.08		1.10	1.20
EPO	Mean	4.09	4.19	0.10		4.21	0.11		4.09	-0.01		3.95	-0.18
	SD	1.32	1.34	0.83		1.20	1.13		1.04	1.28		1.09	1.33
Triglycerides (mmol/l)
Roxa	Mean	1.46	1.35	-0.11	0.301	1.56	0.09	0.413	1.59	0.13	0.243	1.60	0.13	0.471
	SD	1.27	0.84	1.23		1.70	2.08		1.80	1.42		1.74	1.29
EPO	Mean	1.62	1.69	0.07		2.13	0.51		1.14	-0.20		1.54	-0.07
	SD	1.20	1.23	0.52		3.45	0.02		1.18	1.07		1.30	1.29
LDL Cholesterol (mmol/l)
Roxa	Mean	1.30	1.04	-0.26	0.005	1.08	-0.22	0.012	1.17	-0.48	0.017	0.96	-0.46	0.80
	SD	1.13	1.01	0.87		1.04	1.01		1.05	1.07		0.97	0.85
EPO	Mean	2.34	2.41	-0.39		2.38	-0.41		2.34	-0.48		2.18	-0.46
	Sd	1.14	1.14	0.79		1.08	0.82		0.99	1.05		0.97	0.92